🚨 New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms.

🚨 New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it…

New Studies: Pfizer's Paxlovid doesn't actually work, 'rebound' symptoms occur 25x more often than advertised dossier.today/p/new-studies-…

My Paxlovid Files have been ready and waiting for this day for two years.

Hold please. 😉

New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19: “Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it…

Pfizer's paxlovid shown to have no beneficial effects on covid. Ivermectin, by contrast, has been shown many times over to be beneficial...

zerohedge.com/political/pfiz…

'Oops, Paxlovid doesn't work'
- from Pirate Wires

Pfizer got 12 billion dollars from the federal government for Paxlovid. A new Pfizer-funded study says that Paxlovid doesn't work.

If Pfizer-bought doctors are saying it is net inconsequential, it's possible that Paxlovid delivers much worse outcomes than doing nothing at all.

Pfizer projections for 2022 were:

Covid 'vaccine' - $32 Billion

Paxlovid - $22 Billion

Both products don't work.
Ivermectin and hydroxychloroquine worked but were bad for business.

Paxlovid or ivermectin: which is more potent for COVID?

BREAKING: Large RCT published in the #NEJM today fails to find a benefit of #Paxlovid among those at elevated acute risk of COVID.

nejm.org/doi/full/10.10…

Gee, what have I said about Paxlovid day 1? Daniel Horowitz

Pfizer's Paxlovid doesn't work & rebound symptoms occur 25x more often than advertised.

Paxlovid cost taxpayers $12.6 BILLION.

The Pfizer-funded study concluded 7/22, just after it hit shelves. Paper was delayed two years for undisclosed reasons.
dossier.today/p/new-studies-…

Here is an astonishing example from this past week that should have been headline news but was utterly invisible to legacy media The case involves the COVID medication Paxlovid. It was approved under “emergency use” in December 2021, and trumpeted by Fauci, President Biden, and…

On April 3, and with no fanfare, Pfizer published its Phase 2/3 clinical data on the effectiveness of Paxlovid. This paper is a damning indictment of the FDA and the use of EUAs during the covid panic.

Let's look at the data.

Is the antiviral drug Paxlovid a dud?

Of all the antiviral drugs for Covid-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.....…

I’ve used paxlovid in my clinical practice and found it performed poorly. Best in class antiviral is ivermectin 0.6 mg/kg in conjunction with other drugs in McCullough Protocol. petermcculloughmd.com

KOVİD İLACI PAXLOVİD FİYASKOSU
Kovid-19′ da tüm antiviral ilaçlar arasında en başarılı olanı Pfizer’ in Paxlovid’ i oldu.
Emniyeti ve etkinliği açısından değil, çoğu insan için büyük ölçüde etkisiz olmasına rağmen şirkete milyarlarca kâr sağlama becerisi açısından.
Bu,…